4.4 Article

A theoretical study on Zn binding loop mutants instigating destabilization and metal binding loss in human SOD1 protein

Journal

JOURNAL OF MOLECULAR MODELING
Volume 23, Issue 4, Pages -

Publisher

SPRINGER
DOI: 10.1007/s00894-017-3286-z

Keywords

SOD1; ALS; Zn binding loop; Check My Metal; DMD

Ask authors/readers for more resources

Mutations in Cu/Zn superoxide dismutase 1 (SOD1) protein are a major cause of the devastating neurodegenerative disorder Amyotrophic lateral sclerosis. Evidence suggests that SOD1 functions as a free radical scavenger in humans. However, neither the mechanism nor a cure for this neurodegenerative disease are yet known. In the present study, we explored the effect of mutations on the mechanistic action on the Zn binding loop of SOD1 through discrete molecular dynamics. The results were analyzed in detail using statistical potential (BACH) to find the mutant structures having the least potential energy. Subsequently, we studied the impact of those mutations on metal ions bound in SOD1 using the program Check My Metal. Remarkably, our results recognized certain mutants, viz. His80Arg and Asp83Gly, that were more damaging to the Zn binding loop than all other mutants, leading to a loss of Zn binding with altered coordination of the Zn ion. Furthermore, the conformational stability, compactness, and secondary structural alteration of the His80Arg and Asp83Gly mutants were monitored using distinct parameters. Hence, at low computational expense, our study provides helpful insight into this emergent neurodegenerative disorder affecting mankind.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biology

TTRMDB: A database for structural and functional analysis on the impact of SNPs over transthyretin (TTR) using bioinformatic tools

E. Srinivasan, Nandhini Natarajan, R. Rajasekaran

COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis

E. Srinivasan, R. Rajasekaran

JOURNAL OF MOLECULAR NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

Could Dermaseptin Analogue be a Competitive Inhibitor for ACE2 Towards Binding with Viral Spike Protein Causing COVID19?: Computational Investigation

P. Chandra Sekar, R. Rajasekaran

Summary: The study examined the competitive inhibitor activity of a broad spectrum antimicrobial peptide, Dermaseptin-S4 (S4) and its analogues, revealing that S4 (K-4) established more inter-molecular interactions compared to S4 (K4K20) and S1-ACE2. The normal mode analysis (NMA) showed that the S1-S4 (K-4) complex exhibited higher energy deformation profile and conformational transition, suggesting its potential as the best therapeutic scaffold to block SARS-CoV-2 infection.

INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

Unravelling the molecular effect of ocellatin-1, F1, K1 and S1, the frog-skin antimicrobial peptides to enhance its therapeutics-quantum and molecular mechanical approaches

P. Chandra Sekar, D. Meshach Paul, E. Srinivasan, R. Rajasekaran

Summary: Ocellatin AMPs are considered as promising alternatives to conventional antibiotics, with ocellatin-1 peptide showing strong membrane permeability and potential therapeutic efficacy. Computational analyses indicated non-toxicity and membrane-permeable efficacy of ocellatin-1, making it a suitable scaffold for therapeutics. Trajectory analysis further revealed strong structural stability and important role in bacterial membrane penetration, highlighting the therapeutic potential of ocellatin-1 as an antimicrobial drug.

JOURNAL OF MOLECULAR MODELING (2021)

Article Biochemistry & Molecular Biology

In Silico Therapeutic Peptide Design Against Pathogenic Domain Swapped Human Cystatin C Dimer

G. Chandrasekhar, R. Rajasekaran

Summary: In humans, cystatin C mediated amyloid aggregation is harmful, but targeting the protein at the initial pathogenic stage with peptide therapy, specifically the 'LVN' tripeptide, could effectively reduce the aggregation and pathogenic behavior of cystatin C amyloidosis.

INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

Hydrophobic Residues Confer the Helicity and Membrane Permeability of Ocellatin-1 Antimicrobial Peptide Scaffold Towards Therapeutics

P. Chandra Sekar, G. Chandrasekhar, R. Rajasekaran

Summary: Antimicrobial peptides (AMPs) are evolutionarily conserved components of the innate immune system found in all living organisms. Due to their relatively lower microbial drug resistance, AMPs can serve as efficient small molecule drugs. Ocellatin-1 (O1) AMP from the South American frog Leptodactylus ocellatus shows greater efficacy against pathogens due to its unique amino acid residues contributing to its structural stability and functional activity. By analyzing the key residues in O1 AMP, it was found that specific residues like isoleucine and leucine are crucial for maintaining its therapeutic scaffold. Additionally, molecular simulation and computational analysis further confirmed the importance of these residues in O1 AMP for potential drug discovery applications.

INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

Molecular simulation unravels the amyloidogenic misfolding of nascent ApoA1 protein, driven by deleterious point mutations occurring in between 170-178 hotspot region

G. Chandrasekhar, P. Chandra Sekar, E. Srinivasan, A. Amarnath, H. Pengyong, R. Rajasekaran

Summary: The study quantitatively analyzed and investigated the effects of single nucleotide polymorphisms (SNPs) occurring in the 170-178 mutation hotspot site of APoA1 on biomolecular modifications. Results from discrete molecular dynamics simulation studies showed that SNPs significantly altered the behavior of ApoA1 from its native structural dynamics. Analysis of secondary structural changes in the protein revealed considerable alterations post mutations. Additionally, simulated thermal denaturation of the protein structures showed increased resistance to denaturation among mutants compared to native. Further, normal mode analysis of protein's dynamic motion exhibited discrepancies in dynamic structural changes induced by SNPs, which could play a role in driving ApoA1 into its amyloidogenesis.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemical Research Methods

Molecular simulation probes the potency of resveratrol in regulating the toxic aggregation of mutant V30M TTR fibrils in Transthyretin mediated amyloidosis

G. Chandrasekhar, E. Srinivasan, P. Chandra Sekar, S. Venkataramanan, R. Rajasekaran

Summary: The study investigates the subversive nature of point mutation in TTR promoting amyloidogenicity using DMD simulations, and suggests the potential of resveratrol in mitigating the pathogenic repercussions of mutant TTR as an aid towards structure-based drug design in the research on familial amyloid disorders.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2022)

Article Chemistry, Multidisciplinary

Decoding Conformational Imprint of Convoluted Molecular Interactions Between Prenylflavonoids and Aggregated Amyloid-Beta42 Peptide Causing Alzheimer's Disease

E. Srinivasan, G. Chandrasekhar, P. Chandrasekar, K. Anbarasu, A. S. Vickram, Iftikhar Aslam Tayubi, R. Rajasekaran, Rohini Karunakaran

Summary: Protein misfolding leads to the formation of amyloid fibrils associated with neurodegenerative diseases like Alzheimer's disease. Herbal compounds have been identified as potential inhibitors of A beta 42 fibrils, offering a promising approach for AD treatment.

FRONTIERS IN CHEMISTRY (2021)

Review Medicine, General & Internal

Alpha-Synuclein Aggregation in Parkinson's Disease

E. Srinivasan, G. Chandrasekhar, P. Chandrasekar, K. Anbarasu, A. S. Vickram, Rohini Karunakaran, R. Rajasekaran, P. S. Srikumar

Summary: Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopaminergic neurons, with pathogenesis linked to the misfolding and mutations of alpha-synuclein protein. Genetic and other factors lead to the formation of amyloid structures from alpha-synuclein, causing PD.

FRONTIERS IN MEDICINE (2021)

Article Biochemistry & Molecular Biology

Probing the competitive inhibitor efficacy of frog-skin alpha helical AMPs identified against ACE2 binding to SARS-CoV-2 S1 spike protein as therapeutic scaffold to prevent COVID-19

P. Chandra Sekar, E. Srinivasan, G. Chandrasekhar, D. Meshach Paul, G. Sanjay, S. Surya, N. S. Arun Raj Kumar, R. Rajasekaran

Summary: This study compared the intermolecular interactions between the SARS-CoV-2 spike protein S1 and alpha helical AMPs extracted from frog skin, and found that the Spike-Dermaseptin-S9 complex had more interactions. Molecular dynamics and conformational sampling analysis showed that Dermaseptin-S9 can alter the conformation of S1 and maintain high structural stability. Therefore, Dermaseptin-S9 could be a strong candidate for preventing SARS-CoV-2 infection.

JOURNAL OF MOLECULAR MODELING (2022)

Article Biotechnology & Applied Microbiology

Defensin-based therapeutic peptide design in attenuating V30M TTR-induced Familial Amyloid Polyneuropathy

G. Chandrasekhar, H. Pengyong, G. Pravallika, L. Hailei, X. Caixia, R. Rajasekaran

Summary: The study aimed to develop a therapeutic candidate to inhibit the pathogenic misfolding of V30M mutant transthyretin (TTR) protein. The antimicrobial peptide NaD1 was chosen due to its aggregating ability, which could compete with the aggregation-prone regions of TTR protein. Two NaD1-derived tetra peptides, CKTE and SKIL, were proposed as initial candidates based on their association with mutant TTR protein. The CKTE tetra peptide showed significant interaction and therapeutic potential in disrupting the beta-sheets and aggregation of V30M TTR protein.

3 BIOTECH (2023)

Article Chemistry, Multidisciplinary

Therapeutic Role of DGJ (1-deoxygalactonojirimycin) in Fabry Disease: Theoretical Insights

Paul D. D. Meshach, Chandrasekhar Gopalakrishnan, Chandra Sekar Ponnusamy, Udhaya Lavinya, Rajasekaran Ramalingam

Summary: Fabry disease (FD) is a rare genetic disorder caused by the deficiency of the alpha-galactosidase enzyme, resulting in the accumulation of globotriaosylceramide fat. Despite the lack of effective therapeutics, 1-deoxygalactonojirimycin (DGJ) has shown promise as a pharmacological chaperone for alpha-Gal mutants. This study investigates the theoretical details of DGJ's ability to improve the functional activity of specific alpha-Gal mutants through structural and dynamic analysis.

CHEMISTRYSELECT (2023)

No Data Available